BBOTVSERAS• 3 Months (Normalized)
BBOT vs ERAS (BridgeBio Oncology Therapeutics Inc. vs Erasca Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-53.75%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
ERAS Performance $14.74
-21.8%
Erasca Inc.
Normalized Baseline0.00%
Alpha Spread Margin ERAS LEADS
-31.95 pts
ERAS outperforming by 31.95 percentage points
BBOTERAS
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT ERAS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BBOT Price | BBOT Gain (%) | ERAS Price | ERAS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -53.75% | $14.74 | -21.80% | -31.95% |
| Sep 30, 2026 | $4.10 | -51.25% | $- | - | |
| Sep 29, 2026 | $3.92 | -53.39% | $- | - | |
| Sep 28, 2026 | $3.81 | -54.70% | $14.13 | -25.04% | -29.66% |
| Sep 25, 2026 | $3.95 | -53.03% | $14.25 | -24.40% | -28.63% |
| Sep 24, 2026 | $3.99 | -52.56% | $14.52 | -22.97% | -29.59% |
| Sep 23, 2026 | $4.16 | -50.54% | $13.95 | -26.02% | -24.52% |
| Sep 22, 2026 | $4.66 | -44.59% | $15.55 | -17.51% | -27.08% |
| Sep 21, 2026 | $4.66 | -44.59% | $15.04 | -20.21% | -24.38% |
| Sep 18, 2026 | $4.77 | -43.28% | $14.77 | -21.64% | -21.64% |
| Sep 17, 2026 | $4.89 | -41.85% | $15.34 | -18.62% | -23.23% |
| Sep 16, 2026 | $4.76 | -43.40% | $15.36 | -18.51% | -24.89% |
| Sep 15, 2026 | $4.88 | -41.97% | $16.25 | -13.79% | -28.18% |
| Sep 14, 2026 | $5.05 | -39.95% | $16.16 | -14.27% | -25.68% |
| Sep 11, 2026 | $4.95 | -41.14% | $15.88 | -15.76% | -25.38% |
Page 1 of 5